BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12891371)

  • 1. Life beyond synthesis.
    Russo E
    Nature; 2003 Jul; 424(6948):594-6. PubMed ID: 12891371
    [No Abstract]   [Full Text] [Related]  

  • 2. Success in an uneven market.
    Russo E
    Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicinal Chemists of the 21(st) Century--Who Are We and Where to Go?
    Nussbaumer P
    ChemMedChem; 2015 Jul; 10(7):1133-9. PubMed ID: 25924977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Back to basics: from industry to academia.
    Powell K
    Nature; 2004 Aug; 430(7000):706-7. PubMed ID: 15295606
    [No Abstract]   [Full Text] [Related]  

  • 5. A demanding world.
    Smaglik P
    Nature; 2003 Jul; 424(6944):109. PubMed ID: 12840765
    [No Abstract]   [Full Text] [Related]  

  • 6. Journeying through the Field of Medicinal Chemistry: Perspectives from Graduate Researchers.
    Koerperich ZM; Kennelly SA; McDermott CM; Bentz NM; Buchholz CR; Fuller JL; Kilic O; Ge P
    J Med Chem; 2020 Mar; 63(5):1882-1891. PubMed ID: 31913619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The skills hunt.
    Smaglik P
    Nature; 2004 Sep; 431(7004):109. PubMed ID: 15343343
    [No Abstract]   [Full Text] [Related]  

  • 8. Graduate journal: PhD limitations.
    Angerer P
    Nature; 2004 Oct; 431(7012):1128. PubMed ID: 15510156
    [No Abstract]   [Full Text] [Related]  

  • 9. From industry to academia.
    Martin B
    Nature; 2004 May; 429(6989):324-5. PubMed ID: 15152260
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical industry, investigators and institutions: Partners or tools?
    Verweij J
    Eur J Cancer; 2005 Oct; 41(15):2204-5. PubMed ID: 16143515
    [No Abstract]   [Full Text] [Related]  

  • 11. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 12. Breathing life into chemistry.
    Chapman T
    Nature; 2004 Aug; 430(7002):948-9. PubMed ID: 15318243
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug life-cycle technologies.
    Fleming E; Ma P
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract]   [Full Text] [Related]  

  • 14. Can China's supply of scientific talent keep up with demand?
    Wong G
    Nat Biotechnol; 2008 Feb; 26(2):243-4. PubMed ID: 18259182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An eastern promise of regeneration.
    Caruana C
    Nature; 2005 Jun; 435(7044):998-9. PubMed ID: 15959526
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the business of culture.
    Pissarra Pde N
    Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153
    [No Abstract]   [Full Text] [Related]  

  • 17. From targets to targeted treatment solutions.
    Davies N; Peakman T; Arlington S
    Drug Discov Today; 2004 Mar; 9(6):245-7. PubMed ID: 15003240
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemical drug development].
    Castro B
    Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
    [No Abstract]   [Full Text] [Related]  

  • 19. Making the move into drug sales.
    Willerroider M
    Nature; 2004 Jul; 430(6998):486-7. PubMed ID: 15269778
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech in Bangalore.
    Russo G
    Nature; 2008 Apr; 452(7187):660-1. PubMed ID: 18389533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.